US OptionsDetailed Quotes

KURA250516C10000

Watchlist

0.00
0.000.00%

15min DelayClose Apr 30 09:30 ET

0.00High0.00Low

Kura Oncology Stock Discussion

Teddy123

Apr 8 19:37

Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA

$Kura Oncology (KURA.US)$
Breakthrough Cancer Drug for AML Reaches Major FDA Milestone: First-in-Class Treatment

Teddy123

Feb 7 20:37

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

$Kura Oncology (KURA.US)$
Kura Oncology Expands Team with Strategic Stock Options Package - Inside the $8.25/Share Deal

Teddy123

Feb 6 09:53

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

$Kura Oncology (KURA.US)$
Major Clinical Success: AML Drug Breakthrough Shows Promise for Blood Cancer Patients

Teddy123

Oct 1, 2024 12:29

Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology

$Kura Oncology (KURA.US)$
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology | KURA Stock News

J Lim - TTP

Mar 7, 2024 21:51

I like the g/up base with low vol, especially after earnings. High RS98.
$Kura Oncology (KURA.US)$

Kura Oncology(KURA) Pre-Mkt Price 23.160 +2.03%

Moomoo AI

Oct 11, 2023 20:42

Insider selling at Kura Oncology with no purchases in past year could concern investors. More ideally, insider ownership percentage would be higher. Yet, implications aren't set in stone, consider other company-specific risks.

Kura Oncology Repeat Insider Selling Not A Positive Indicator

Alvinnnnnnngenius

Dec 12, 2022 22:34

Halt down

$Kura Oncology (KURA.US)$

No comment yet